CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 760	$ 564
Restricted cash	20	27
Trade receivables, net	1,948	1,790
Inventories, net	1,272	1,090
Prepaid expenses and other current assets	1,048	776
Total current assets	5,048	4,247
Property, plant and equipment, net	1,584	1,600
Intangible assets, net	6,728	5,800
Goodwill	11,187	11,547
Deferred tax assets, net	2,189	2,166
Other non-current assets	328	326
Total assets	27,064	25,686
Current liabilities:
Accounts payable	569	521
Accrued and other current liabilities	3,119	2,988
Current portion of long-term debt	536	432
Total current liabilities	4,224	3,941
Acquisition-related contingent consideration	247	208
Non-current portion of long-term debt	21,894	20,334
Deferred tax liabilities, net	213	202
Other non-current liabilities	721	741
Total liabilities	27,299	25,426
Commitments and contingencies (Note 17)
(Deficit) Equity
Common shares, no par value, unlimited shares authorized, 365,043,317 and 361,898,846 issued and outstanding at September 30, 2023 and December 31, 2022, respectively	10,420	10,391
Additional paid-in capital	190	159
Accumulated deficit	(9,739)	(9,186)
Accumulated other comprehensive loss	(2,051)	(2,056)
Total Bausch Health Companies Inc. shareholders’ deficit	(1,180)	(692)
Noncontrolling interest	945	952
Total (deficit) equity	(235)	260
Total liabilities and (deficit) equity	$ 27,064	$ 25,686